1 |
Hewitt, M. & Servos, M. An Overview of Substances Present in Canadian Aquatic Environments Associated with Endocrine Disruption. Water Qual. Res. J. Canada. 36, 191-213(2001)
|
2 |
Smeds, A. & Saukko, P. Identification and quantification of polychlorinated bisphenols and some endocrine disrupting pesticides in human adipose tissue from Finland. Chemosphere 44, 1463-1471 (2001)
DOI
ScienceOn
|
3 |
Sole, R.V., Bonabeau, E., Delgado, J., Fernandez, P. & Marin, J. Pattern formation and optimization in army ant raids. Artificial Life 6, 219-226 (2000)
DOI
ScienceOn
|
4 |
Schena, M., Shalon, D., Davis, R.W. & Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470 (1995)
DOI
PUBMED
ScienceOn
|
5 |
Nuwaysir, E.F., Bittner, M., Trent, J., Barrett, J.C. Afshari, C.A. Microarrays and toxicology : the advent of toxicogenomics, Mol. Carcinog. 24, 153-159 (1999)
DOI
ScienceOn
|
6 |
Leung, L.K. & Wang, T.T. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7. Br. J. Cancer. 81, 387-392 (1999).
DOI
ScienceOn
|
7 |
Tusher, V., Tribshirani, R. & Chu, C. Significance analysis of microarrays applied to ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001)
DOI
ScienceOn
|
8 |
Terasaka, S. et al. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ. Health Perspect. 112, 773-781 (2004)
DOI
ScienceOn
|
9 |
Fox, G.A. Effects of endocrine disrupting chemicals on wildlife in Canada: past, present, and future. Water Qual. Res. J. Can. 26, 233-251 (2001)
DOI
ScienceOn
|
10 |
Inoue, T. Toxicogenomics- a new paradigm of toxicology. In: Toxicogenomics (Inoue, T., Pennie, W. D., eds). Tokyo: Springer, 3-11 (2003)
|
11 |
Kumar, P., Mark, P.J., Ward, B.K., Minchin, R.F. & Ratajczak, T. Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF- 7 breast cancer cells. Biochem. Biophys. Res. Commun. 284, 219-225 (2001)
|
12 |
Li, S.S. & Hou, E.W. Estrogen-induced expression of mouse lactate dehydrogenase-A gene. Cell Biol. Int. Rep. 13, 619-624 (1989)
DOI
ScienceOn
|
13 |
Gaido, K.W., Leonard, L.S., Lovell, S., Gould, J.C., Babai, D., Portier, C.J. & McDonnell, D.P. Evaluation of chemicals with endocrine modulating activity in a Yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143, 205- 212 (1997).
DOI
ScienceOn
|
14 |
Soulez, M. & Parker, M.G. Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J. Mol. Endocrinol. 27, 259-274 (2001)
DOI
ScienceOn
|
15 |
Lister, A.L. & Kraak, GJVD. Endocrine disruption : why is it so complicated? Water Qual. Res. J. Can. 36, 175-190 (2001)
|
16 |
Birkett, J.W. & Lester, J.N. Endocrine Disrupters in Wastewater and Sludge Treatment Processes. Boca Raton, FL: CRC Press. (2003)
|
17 |
Zhang, H., Yu, C.Y. & singer, B. Cell and tumor classification using gene expression data : Construction of forests. Proc. Natl. Acad. Sci. USA 100, 4168- 4172 (2003)
DOI
ScienceOn
|
18 |
Nilsen, B.M., Berg, K., Eidem, J.K., Kristiansen, S. I., Brion, F., Porcher, J.M. & Goksoyr, A. Development of quantitative vitellogenin-ELISAs for fish test species used in endocrine disruptor screening. Anal. Bioanal. Chem. 378, 621-633 (2004)
DOI
ScienceOn
|
19 |
Takeyoshi, M., Yamasaki, K., Sawaki, M., Nakai, M., Noda, S. & Takatsuki, M. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions. Toxicol. Lett. 126, 91-98 (2002)
DOI
ScienceOn
|
20 |
Charpentier, A.H., Bednarek, A.K., Daniel, R.L., Hawkins, K.A., Laflin, K.J., Gaddis, S., MacLeod, M.C. & Aldaz, C.M. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res. 60, 5977-5983(2000)
|
21 |
Afshari, C.A., Nuwaysir, E.F. & Barrett, J.C. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res. 59, 4759-4760 (1999)
|
22 |
Francois, E., Wang, D.Y., Fulthorpe, R., Liss, S.N. & Edwards, E. A. DNA microarrays for detecting endocrine- disrupting compounds. Biotechno. Advances 22, 17-26 (2003)
DOI
ScienceOn
|
23 |
Huang, C.H. & Sedlak, D.L. Analysis of estrogenic hormones in municipal wastewater effluent and surface water using ELISA and GC/MS/MS. Environ. Toxicol. Chem. 20, 133-139 (2001)
DOI
ScienceOn
|
24 |
Inoue, A., Yoshida, N., Omoto, Y., Oguchi, S., Yamori, T. & Kiyama, R. Development of cDNA microarray for expression profiling of estrogen responsive genes. J. Mol. Endocrinol. 29, 175-192 (2002)
DOI
ScienceOn
|
25 |
Chen, I., Hsieh, T., Thomas, T. & Safe, S. Identification of estrogen-induced genes downregulated by AhR agonists in MCF-7 breast cancer cells using suppression subtractive hybridization. Gene 262, 207- 214 (2001)
DOI
PUBMED
ScienceOn
|
26 |
Imanishi, S., Manabe, N., Nishizawa, H., Morita, M., Sugimoto, M., Iwahori, M. & Miyamoto, H. Effects of oral exposure of bisphenol A on mRNA expression of nuclear receptors in murine placentae assessed by DNA microarray. J. Reprod. Dev. 49, 329-336 (2003)
DOI
ScienceOn
|
27 |
Nielsen, M., Hoyer, P.E., Lemmen, J.G., van der Burg, B. & Byskov, A.G. Octylphenol does not mimic diethylstilbestrol-induced oestrogen receptor-alpha expression in the newborn mouse uterine epithelium after prenatal exposure. J. Endocrinol. 167, 29-37 (2000)
DOI
ScienceOn
|
28 |
Sawai, T., Bernier, F., Fukushima, T., Hashimoto, T., Ogura, H. & Nishizawa, Y. Estrogen induces a rapid increase of calcium-calmodulin-dependent protein kinase II activity in the hippocampus. Brain Res. 950, 308-311 (2002)
DOI
PUBMED
ScienceOn
|
29 |
Abbott, D.W., Laszczak, M., Lewis, J.D., Su, H., Moore, S.C., Hills, M., Dimitrov, S. & Ausio, J. Structural characterization of macroH2A containing chromatin. Biochemistry 43, 1352-1359 (2004)
|
30 |
Chee, M., Yang. et al. Accessing genetic information with high-density DNA arrays. Science 274, 610-614 (1996)
DOI
PUBMED
ScienceOn
|
31 |
Skakkebaek, N.E. Endocrine disrupters and testicular dysgenesis syndrome. Horm. Res. 57, 43(2002)
DOI
ScienceOn
|
32 |
Abraham, G.E. The Applications of Steroid Radioimmunoassay to Gynecologic Endocrinology. Prog. Gynecol. 1, 111-144 (1975)
|
33 |
Byrne, J.A., Mattei, M.G., Basset, P. & Gunning, P. Identification and in situ hybridization mapping of a mouse Tpd5211 (D53) orthologue to chromosome 10A4-B2. Cytogenet. Cell Genet. 81, 199-201 (1998).
DOI
ScienceOn
|
34 |
Phillips, B. & Harrison, P. Overview of the endocrine disrupters issue. In: Hester RE, Harrison RM, editors. Issues in environmental science and technology, vol 12: endocrine disrupting chemicals, vol 12. Cambridge (UK): Royal Society of Chemistry; (1-26) (1999)
|
35 |
Jobling, M.A., Bouzekri, N. & Taylor, P.G. Hypervariable digital DNA codes for human paternal lineages: MVR-PCR at the Y-specific minisatellite, MSY1 (DYF155S1). Human Mol. Genet. 7, 643-653(1998)
DOI
ScienceOn
|
36 |
McMaster, M.E. A review of the evidence for endocrine disruption in Canadian aquatic ecosystems. Water Qual. Res. J. Can. 36, 215-231 (2001)
|